Home > Transparency Posts > Transparency Meeting with Investors & FDA

Transparency Meeting with Investors & FDA

August 12, 2009

Attendees


Transparency Meeting with Investors & FDA


August 11, 2009, 9:30 – 11:00am, EEOB 350


  


Barry Eisenstein, Cubist


Scott Minick, ARCH


Jonathan Flemming, Oxbio


John H. Griffin, Numerate, Inc.


Mike Ross, SV Life Sciences


Michael Doherty, Genentech


Vern Norviel, WSGR


Jonathan Fleming, Oxford Bioscience Partners


William Rosenzweig, Physic Ventures


Jonathan S. Leff, Warburg Pincus


Kelly Slone, NVCA


Justin Klein, NEA

Follow

Get every new post delivered to your Inbox.

Join 175 other followers

%d bloggers like this: